The skin microbiome and its importance in atopic dermatitis (AD) is being revealed with more and more investigations, and some therapeutic products aimed at minimizing the influence of staph aureus on the skin of patients with AD are now available.

A symposium held at the annual meeting of the Canadian Dermatology Association (CDA) in June focused on the role of the skin microbiome in dermatological diseases. The human microbiome represents a source of genetic diversity, a modifier of disease, and an essential component of immunity and is composed of microbes that live in and on human bodies.1

Molecular technology has permitted investigations to contrast the normal human microbiome with changes in skin which has been affected by various disease states.

Read the full article at dermatologytimes.modernmedicine.com.